Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NET-EN for Recurrent Bacterial Vaginosis
NCT02905890Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Oct 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of norethisterone enanthate in bacterial vaginosis (BV) (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Time to diagnosis of recurrent BV at 6 months. Started Oct 2017; status: completed.
02
Drugs
norethisterone enanthate
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02905890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02905890.